VF
CALA

Virtu Financial’s Calithera Biosciences, Inc CALA Stock Holding History

Virtu Financial’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15,456
Closed -$38K – 2553
2022
Q2 		$38K Buy
15,456
+10,035
+185% +$46.5K ﹤0.01% 1196
2022
Q1 		$44K Sell
5,421
-6,189
-53% -$63.2K ﹤0.01% 1169
2021
Q4 		$154K Buy
11,610
+10,721
+1,206% +$269K 0.02% 942
2021
Q3 		$39K Buy
+889
New +$38.4K ﹤0.01% 1308
2021
Q2 		– Sell
-1,072
Closed -$52K – 2334
2021
Q1 		$52K Buy
+1,072
New +$62.4K ﹤0.01% 1430
2020
Q4 		– Sell
-896
Closed -$62K – 1933
2020
Q3 		$62K Buy
+896
New +$78.2K 0.01% 792
2019
Q4 		– Sell
-1,530
Closed -$95K – 1987
2019
Q3 		$95K Buy
+1,530
New +$122K 0.01% 1101
2019
Q1 		– Sell
-610
Closed -$49K – 2022
2018
Q4 		$49K Buy
+610
New +$60.2K ﹤0.01% 1269
2017
Q4 		– Sell
-881
Closed -$277K – 3213
2017
Q3 		$277K Buy
+881
New +$278K 0.01% 1464

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Virtu Financial's CALA Position: Q3 2022 in Review

Virtu Financial sold out of Calithera Biosciences, Inc (CALA) in Q3 2022, closing a stake of 15,456 shares — an estimated $38K sold.

Virtu Financial first reported a position in CALA in Q3 2017 and held it in 9 quarters. The position peaked at $277K in Q3 2017. 22 funds tracked by Wall St. Rank hold CALA as of Q3 2022.

  • Virtu Financial reported no remaining Calithera Biosciences, Inc position as of Q3 2022 after selling out during the quarter.
  • Virtu Financial sold 15,456 Calithera Biosciences, Inc shares in Q3 2022, an estimated $38K.
  • Virtu Financial first reported a position in Calithera Biosciences, Inc in Q3 2017 and held it in 9 quarters.
  • Virtu Financial's Calithera Biosciences, Inc position peaked at $277K in Q3 2017.
  • 22 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2022.

Based on Virtu Financial's 13F filing for Q3 2022, filed 7 Nov 2022.